MEETINGS - Investment in Innovation (Belgium) September 2005:
This article was originally published in Clinica
Medtech Insight will host In3: Investment in Innovation, a preview of early-stage medical technology companies, through two events. One at the Crowne Plaza in Brussels, Belgium on September 20-21 2005 and the other at The Westin Copley Place in Boston, Massachusetts on October 10-11. For further information on both events, visit: http://www.medtechinsight.com/conferences.html
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.